The biotech sector in Q3 2024 experienced a dynamic landscape characterized by advancements in AI-powered drug discovery and fluctuating venture…
The biotech sector in Q3 2024 experienced a dynamic landscape characterized by advancements in AI-powered drug discovery and fluctuating venture…